Advanced Enzyme Technologies Limited (BOM:540025)

Market Cap	33.68B -9.0%
Revenue (ttm)	7.10B +13.1%
Net Income	1.52B +14.5%
EPS	13.59 +14.5%
Shares Out	n/a
PE Ratio	22.13
Forward PE	20.08
Dividend	5.20 (1.73%)
Ex-Dividend Date	Jul 23, 2025

Volume	5,249
Average Volume	8,648
Open	301.00
Previous Close	305.75
Day's Range	297.30 - 302.35
52-Week Range	257.85 - 366.55
Beta	n/a
RSI	54.90
Earnings Date	Jan 31, 2026

About BOM:540025

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Industrial Organic Chemicals
• Founded: 1957
• Employees: 338
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540025

Financial Performance

In fiscal year 2025, BOM:540025's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.